CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy
The CRAFITY-100 RULE provided clearer stratification and higher discrimination. This simple model integrating baseline and dynamic biomarkers may assist clinical decision-making in unresectable HCC treated with immunotherapy.
Authors
- Ying‐Cheng Lin (ORCID: https://orcid.org/0000-0002-7665-0988)
- Hsin‐Ju Tsai (ORCID: https://orcid.org/0000-0002-0535-7960)
- Yen-Chun Peng (ORCID: https://orcid.org/0000-0002-8993-3039)
- Chung‐Hsin Chang
- Shou‐Wu Lee (ORCID: https://orcid.org/0000-0002-2412-2665)
- Chia‐Chang Chen (ORCID: https://orcid.org/0000-0002-4407-2052)
- Teng‐Yu Lee (ORCID: https://orcid.org/0000-0002-4097-4315)
- Yi-Jie Huang
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-18
- DOI
- https://doi.org/10.3390/cancers17183058
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64